Inhibition of Bone Morphogenetic Protein Signal Transduction Prevents the Medial Vascular Calcification Associated with Matrix Gla Protein Deficiency

Objective Matrix Gla protein (MGP) is reported to inhibit bone morphogenetic protein (BMP) signal transduction. MGP deficiency is associated with medial calcification of the arterial wall, in a process that involves both osteogenic transdifferentiation of vascular smooth muscle cells (VSMCs) and mesenchymal transition of endothelial cells (EndMT). In this study, we investigated the contribution of BMP signal transduction to the medial calcification that develops in MGP-deficient mice. Approach and Results MGP-deficient mice (MGP-/-) were treated with one of two BMP signaling inhibitors, LDN-193189 or ALK3-Fc, beginning one day after birth. Aortic calcification was assessed in 28-day-old mice by measuring the uptake of a fluorescent bisphosphonate probe and by staining tissue sections with Alizarin red. Aortic calcification was 80% less in MGP-/- mice treated with LDN-193189 or ALK3-Fc compared with vehicle-treated control animals (P<0.001 for both). LDN-193189-treated MGP-/- mice survived longer than vehicle-treated MGP-/- mice. Levels of phosphorylated Smad1/5 and Id1 mRNA (markers of BMP signaling) did not differ in the aortas from MGP-/- and wild-type mice. Markers of EndMT and osteogenesis were increased in MGP-/- aortas, an effect that was prevented by LDN-193189. Calcification of isolated VSMCs was also inhibited by LDN-193189. Conclusions Inhibition of BMP signaling leads to reduced vascular calcification and improved survival in MGP-/- mice. The EndMT and osteogenic transdifferentiation associated with MGP deficiency is dependent upon BMP signaling. These results suggest that BMP signal transduction has critical roles in the development of vascular calcification in MGP-deficient mice.

[1]  Michael Joner,et al.  Has Our Understanding of Calcification in Human Coronary Atherosclerosis Progressed? , 2014, Arteriosclerosis, thrombosis, and vascular biology.

[2]  G. Hunter,et al.  Peptides of Matrix Gla Protein Inhibit Nucleation and Growth of Hydroxyapatite and Calcium Oxalate Monohydrate Crystals , 2013, PloS one.

[3]  K. Boström,et al.  A Role for the Endothelium in Vascular Calcification , 2013, Circulation research.

[4]  J. Uitto,et al.  Vitamin K-dependent carboxylation of matrix Gla-protein: a crucial switch to control ectopic mineralization. , 2013, Trends in molecular medicine.

[5]  E. Boerwinkle,et al.  Matrix Gla Protein Gene Polymorphism Is Associated With Increased Coronary Artery Calcification Progression , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[6]  Li-feng Sun,et al.  Tracheobronchial stenosis in keutel syndrome , 2012, Indian Pediatrics.

[7]  Yong Sun,et al.  Smooth Muscle Cell–Specific Runx2 Deficiency Inhibits Vascular Calcification , 2012, Circulation research.

[8]  P. ten Dijke,et al.  BMP signaling in vascular diseases , 2012, FEBS letters.

[9]  E. Aikawa,et al.  Inhibition of Bone Morphogenetic Protein Signaling Reduces Vascular Calcification and Atherosclerosis , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[10]  G. Lajoie,et al.  Matrix Gla protein inhibits ectopic calcification by a direct interaction with hydroxyapatite crystals. , 2011, Journal of the American Chemical Society.

[11]  W. C. O'Neill,et al.  Matrix Gla Protein Metabolism in Vascular Smooth Muscle and Role in Uremic Vascular Calcification* , 2011, The Journal of Biological Chemistry.

[12]  A. Nohe,et al.  Bone morphogenetic proteins: a critical review. , 2011, Cellular signalling.

[13]  H. Matsubara,et al.  Paracrine Osteogenic Signals via Bone Morphogenetic Protein-2 Accelerate the Atherosclerotic Intimal Calcification In Vivo , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[14]  Yin Tintut,et al.  Regulatory mechanisms in vascular calcification , 2010, Nature Reviews Cardiology.

[15]  Xianwu Li,et al.  Runx2/Cbfa1, but not loss of myocardin, is required for smooth muscle cell lineage reprogramming toward osteochondrogenesis , 2010, Journal of cellular biochemistry.

[16]  Brian J. Bennett,et al.  Inhibition of bone morphogenetic protein protects against atherosclerosis and vascular calcification , 2010, Circulation research.

[17]  D. Dichek,et al.  Smooth Muscle Cells Give Rise to Osteochondrogenic Precursors and Chondrocytes in Calcifying Arteries , 2009, Circulation research.

[18]  S. Booth,et al.  Matrix Gla protein polymorphisms are associated with coronary artery calcification in men. , 2009, Journal of nutritional science and vitaminology.

[19]  K. Amann.  Media calcification and intima calcification are distinct entities in chronic kidney disease. , 2008, Clinical journal of the American Society of Nephrology : CJASN.

[20]  H. Aburatani,et al.  BMP2 Regulates Osterix through Msx2 and Runx2 during Osteoblast Differentiation* , 2008, Journal of Biological Chemistry.

[21]  Randall T Peterson,et al.  Structure-activity relationship study of bone morphogenetic protein (BMP) signaling inhibitors. , 2008, Bioorganic & medicinal chemistry letters.

[22]  R. Weissleder,et al.  Notch Signaling in Cardiovascular Disease and Calcification , 2008, Current cardiology reviews.

[23]  J. Kappes,et al.  Oxidative Stress Induces Vascular Calcification through Modulation of the Osteogenic Transcription Factor Runx2 by AKT Signaling* , 2008, Journal of Biological Chemistry.

[24]  Timur Shtatland,et al.  Osteogenesis Associates With Inflammation in Early-Stage Atherosclerosis Evaluated by Molecular Imaging In Vivo , 2007, Circulation.

[25]  Renu Virmani,et al.  Pathology of the vulnerable plaque. , 2007, Journal of the American College of Cardiology.

[26]  K. Kinzler,et al.  A protocol for rapid generation of recombinant adenoviruses using the AdEasy system , 2007, Nature Protocols.

[27]  Ralph Weissleder,et al.  Multimodality Molecular Imaging Identifies Proteolytic and Osteogenic Activities in Early Aortic Valve Disease , 2007, Circulation.

[28]  J. Loscalzo,et al.  Vascular Calcification: Pathobiological Mechanisms and Clinical Implications , 2006, Circulation research.

[29]  K. Boström,et al.  Regulation of Bone Morphogenetic Protein-4 by Matrix GLA Protein in Vascular Endothelial Cells Involves Activin-like Kinase Receptor 1* , 2006, Journal of Biological Chemistry.

[30]  Shmuel Einav,et al.  A hypothesis for vulnerable plaque rupture due to stress-induced debonding around cellular microcalcifications in thin fibrous caps , 2006, Proceedings of the National Academy of Sciences.

[31]  C. Shanahan,et al.  Molecular mechanisms mediating vascular calcification: Role of matrix Gla protein (Review Article) , 2006, Nephrology.

[32]  D. Towler,et al.  Molecular mechanisms of vascular calcification: lessons learned from the aorta. , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[33]  Y. Tintut,et al.  Vascular calcification: mechanisms and clinical ramifications. , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[34]  D. Towler,et al.  Osteogenic regulation of vascular calcification: an early perspective. , 2004, American journal of physiology. Endocrinology and metabolism.

[35]  K. Boström,et al.  Matrix GLA protein and BMP‐2 regulate osteoinduction in calcifying vascular cells , 2003, Journal of cellular biochemistry.

[36]  E. Fisher,et al.  Transdifferentiation of mouse aortic smooth muscle cells to a macrophage-like state after cholesterol loading , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[37]  R. Guldberg,et al.  Inactivation of the Osteopontin Gene Enhances Vascular Calcification of Matrix Gla Protein–deficient Mice , 2002, The Journal of experimental medicine.

[38]  M. Roy,et al.  Matrix Gla protein binding to hydroxyapatite is dependent on the ionic environment: calcium enhances binding affinity but phosphate and magnesium decrease affinity. , 2002, Bone.

[39]  K. Boström,et al.  Matrix GLA Protein, a Regulatory Protein for Bone Morphogenetic Protein-2* , 2002, The Journal of Biological Chemistry.

[40]  R. Aebersold,et al.  Smooth Muscle Cell Phenotypic Transition Associated With Calcification: Upregulation of Cbfa1 and Downregulation of Smooth Muscle Lineage Markers , 2001, Circulation research.

[41]  Roger D. Kamm,et al.  The Impact of Calcification on the Biomechanical Stability of Atherosclerotic Plaques , 2001, Circulation.

[42]  J. Wozney,et al.  Runx2 Is a Common Target of Transforming Growth Factor β1 and Bone Morphogenetic Protein 2, and Cooperation between Runx2 and Smad5 Induces Osteoblast-Specific Gene Expression in the Pluripotent Mesenchymal Precursor Cell Line C2C12 , 2000, Molecular and Cellular Biology.

[43]  D. Sane,et al.  Modulation of the Binding of Matrix Gla Protein (MGP) to Bone Morphogenetic Protein-2 (BMP-2) , 2000, Thrombosis and Haemostasis.

[44]  R. Jilka,et al.  Essential Requirement of BMPs‐2/4 for Both Osteoblast and Osteoclast Formation in Murine Bone Marrow Cultures from Adult Mice: Antagonism by Noggin , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[45]  I. Shapiro,et al.  Matrix Gla Protein Is a Developmental Regulator of Chondrocyte Mineralization And, When Constitutively Expressed, Blocks Endochondral and Intramembranous Ossification in the Limb , 1999, The Journal of cell biology.

[46]  U. Hedin,et al.  Control of Smooth Muscle Cell Proliferation – The Role of the Basement Membrane , 1999, Thrombosis and Haemostasis.

[47]  R. Behringer,et al.  Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein , 1997, Nature.

[48]  A. Boskey,et al.  Osteopontin-hydroxyapatite interactions in vitro: inhibition of hydroxyapatite formation and growth in a gelatin-gel. , 1993, Bone and mineral.

[49]  K. Watson,et al.  Bone morphogenetic protein expression in human atherosclerotic lesions. , 1993, The Journal of clinical investigation.

[50]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[51]  P. Gabriel,et al.  [A new autosomal-recessive hereditary syndrome. Multiple peripheral pulmonary stenosis, brachytelephalangia, inner-ear deafness, ossification or calcification of cartilages]. , 1971, Deutsche medizinische Wochenschrift.

[52]  FumiyukiOtsuka,et al.  Has Our Understanding of Calcification in Human Coronary Atherosclerosis Progressed , 2014 .

[53]  R. Kalluri,et al.  Conversion of vascular endothelial cells into multipotent stem-like cells , 2010, Nature Medicine.

[54]  P. Munroe,et al.  Mutations in the gene encoding the human matrix Gla protein cause Keutel syndrome , 1999, Nature Genetics.